scholarly article | Q13442814 |
P356 | DOI | 10.1002/MRM.24869 |
P698 | PubMed publication ID | 23878023 |
P50 | author | Siver Andreas Moestue | Q42637173 |
Tone F. Bathen | Q61104171 | ||
Ingrid Susann Gribbestad | Q65706743 | ||
Gunhild M. Mælandsmo | Q76257274 | ||
Morteza Esmaeili | Q101578666 | ||
Olav Engebråten | Q114422039 | ||
P2860 | cites work | Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 |
Molecular portraits of human breast tumours | Q28032461 | ||
The emerging mechanisms of isoform-specific PI3K signalling | Q29617954 | ||
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity | Q29618117 | ||
Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis | Q30514230 | ||
Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo | Q31009512 | ||
Tumour phospholipid metabolism | Q33179622 | ||
Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cells | Q33564297 | ||
Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models | Q33660965 | ||
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells | Q33699139 | ||
Evaluation of the ERETIC method as an improved quantitative reference for 1H HR-MAS spectroscopy of prostate tissue | Q33890692 | ||
The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy. | Q33959529 | ||
In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response | Q34016780 | ||
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy | Q34140986 | ||
17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2 | Q34989144 | ||
In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literature | Q36245493 | ||
Mouse models in oncogenesis and cancer therapy. | Q36499581 | ||
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer | Q36903072 | ||
Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy. | Q37100440 | ||
Triple-negative breast cancer: present challenges and new perspectives | Q37764168 | ||
Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation | Q37779171 | ||
Does the PI3K pathway play a role in basal breast cancer? | Q37813284 | ||
Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy | Q37871191 | ||
Targeting the PI3K signaling pathway in cancer therapy | Q37975242 | ||
PI3K and MEK inhibitor combinations: examining the evidence in selected tumor types | Q38084846 | ||
Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells. | Q40428146 | ||
Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models | Q41128277 | ||
Modulation of MR-visible mobile lipid levels by cell culture conditions and correlations with chemotactic response | Q41238551 | ||
Glycerol 3-phosphate and lactate as indicators of the cerebral cytoplasmic redox state in severe and mild hypoxia respectively: a 13C- and 31P-n.m.r. study | Q41829015 | ||
Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy | Q41939336 | ||
Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using (1)H and (31)P magic angle spinning MRS of intact tissue | Q44545551 | ||
31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia | Q44673076 | ||
1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. | Q45863255 | ||
High-resolution magic-angle-spinning 1H NMR spectroscopy reveals different responses in choline-containing metabolites upon gene therapy-induced programmed cell death in rat brain glioma. | Q45883454 | ||
Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters | Q46756319 | ||
Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells | Q46908003 | ||
Evaluation of 31P high-resolution magic angle spinning of intact tissue samples | Q48449228 | ||
Use of Voigt lineshape for quantification of in vivo 1H spectra | Q48722469 | ||
Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling. | Q51541687 | ||
Concentration measurements by PULCON using X-filtered or 2D NMR spectra | Q57825681 | ||
Measuring Protein Concentrations by NMR Spectroscopy | Q57825691 | ||
P433 | issue | 6 | |
P921 | main subject | xenograft | Q64148587 |
P304 | page(s) | 1973-1981 | |
P577 | publication date | 2013-07-22 | |
P1433 | published in | Magnetic Resonance in Medicine | Q6731496 |
P1476 | title | Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts | |
P478 | volume | 71 |
Q37474359 | Effects of tyrosine kinase inhibitors and CXCR4 antagonist on tumor growth and angiogenesis in rat glioma model: MRI and protein analysis study. |
Q26751944 | Evaluation of Cancer Metabolomics Using ex vivo High Resolution Magic Angle Spinning (HRMAS) Magnetic Resonance Spectroscopy (MRS) |
Q64252558 | HR-MAS NMR Based Quantitative Metabolomics in Breast Cancer |
Q57095807 | High-resolution magic-angle-spinning NMR spectroscopy of intact tissue |
Q36822535 | Intratumoral Agreement of High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopic Profiles in the Metabolic Characterization of Breast Cancer |
Q36918102 | MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival. |
Q58086874 | Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma |
Q40403745 | Metabolomic changes during cellular transformation monitored by metabolite-metabolite correlation analysis and correlated with gene expression |
Q40071956 | Pitfalls to be considered on the metabolomic analysis of biological samples by HR-MAS. |
Q37660266 | Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation |
Q42120404 | Probing the PI3K/Akt/mTor pathway using (31)P-NMR spectroscopy: routes to glycogen synthase kinase 3. |
Search more.